Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus®
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 21577206
Leung WK, et al. (2011) A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility. Oncogene 30, 4464-75 21577206
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Information from this record has been curated, but not yet edited in PhosphoSitePlus® and may be incomplete.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S83-p - TAGLN2 (human)
Modsite: PVkkIQAstMAFkQM SwissProt Entrez-Gene
Orthologous residues
TAGLN2 (human): S83‑p, TAGLN2 (mouse): S83‑p, TAGLN2 (rat): S83‑p
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE CDK14 (human)

S163-p - TAGLN2 (human)
Modsite: kENPRNFsDNQLQEG SwissProt Entrez-Gene
Orthologous residues
TAGLN2 (human): S163‑p, TAGLN2 (mouse): S163‑p, TAGLN2 (rat): S163‑p
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE CDK14 (human)